Application of Nanomaterials for Drug Innovation and Their Risks |
| S. Tsunoda and Y. Tsutsumi |
| J. Pharm. Soc. Jpn., 128(12),1713-1714, 2008 |
|
Evaluation of Biological Influence of Nano-materials using Toxicokinetic and Toxicoproteomic Approach |
| T. Yoshikawa, H. Nabeshi, and Y. Yoshioka |
| J. Pharm. Soc. Jpn., 128(12),1715-1725, 2008 |
|
Hazard Identification of Nanomaterials |
| H. Tsuda, H. Tokunaga, A. Hirose, and J. Kanno |
| J. Pharm. Soc. Jpn., 128(12),1727-1732, 2008 |
|
Development of PEGylated Adenovirus Vector for Cancer Gene Therapy |
| Y. Eto, Y. Yoshioka, R. Asavatanabodee, H. Mizuguchi, Y. Mukai, N. Okada, and S. Nakagawa |
| J. Pharm. Soc. Jpn., 128(12),1733-1742, 2008 |
|
Development and Application of Glycosylated Particulate Carriers for Delivery of Nucleic Acid Medicine |
| S. Kawakami |
| J. Pharm. Soc. Jpn., 128(12),1743-1749, 2008 |
|
Development of a Replication-incompetent Adenovirus Vector Derived from Subgroup B Adenovirus Serotype 35 |
| F. Sakurai |
| J. Pharm. Soc. Jpn., 128(12),1751-1761, 2008 |
|
Intracellular Survival and Replication of Legionella Pneumophila within Host Cells |
| M. Miyake |
| J. Pharm. Soc. Jpn., 128(12),1763-1770, 2008 |
|
In Vitro Screening of Psychoactive Drugs to Prevent the Abuses |
| K. Satoh and R. Nonaka |
| J. Pharm. Soc. Jpn., 128(12),1771-1782, 2008 |
|
Pharmacoeconomic Analysis of Hypertriglyceridemia Treatment at the Medical Institutions |
| T. Takahashi, Y. Saegusa, Y. Takimoto, and M. Shiragami |
| J. Pharm. Soc. Jpn., 128(12),1783-1789, 2008 |
|
In Vitro and Clinical Evaluation of an Oral Mucosal Adhesive Film Containing Indomethacin |
| K. Takeuchi, M. Watanabe, M. Yanagi, I. Murakami, H. Hosono, S. Nishizawa, Y. Chigono, S. Hirabayashi, J. Matsuda, K. Yamaoka, and K. Inoue |
| J. Pharm. Soc. Jpn., 128(12),1791-1795, 2008 |
|
The Derivatives of Phenylpentanone in Cultured Mycelium of Mycoleptodonoides aitchisonii and the Syntheses of Their Compounds |
| K. Satoh, T. Yamashiro, M. Nomura, and S. Nakata |
| J. Pharm. Soc. Jpn., 128(12),1797-1802, 2008 |
|
Relationship between Patient Profile and Feverishness Developed during Interferon-Ribavirin Combination Therapy of Chronic Hepatitis C Patients |
| E. Motegi, Y. Uesawa, Y. Dai, K. Ishii, and K. Mohri |
| J. Pharm. Soc. Jpn., 128(12),1803-1810, 2008 |
|
Retrospective Serological Tests for Determining the Optimal Blood Concentration of Voriconazole for Treating Fungal Infection |
| T. Okuda, A. Okuda, N. Watanabe, M. Takao, and K. Takayanagi |
| J. Pharm. Soc. Jpn., 128(12),1811-1818, 2008 |
|
The Actual State of Medical Activities as “Home Pharmacy” Including Preventive Medicine in Community Pharmacy and Their Regional Differences |
| J. Suzuki, Y. Ohtsu, M. Hashimoto, and F. Kaiho |
| J. Pharm. Soc. Jpn., 128(12),1819-1831, 2008 |
|
Convenient TLC-based Identification Test for the Crude Drug “Pogostemoni Herba” |
| Y. Amakura, M. Yoshimura, C. Mouri, M. Mikage, N. Kawahara, Y. Goda, and T. Yoshida |
| J. Pharm. Soc. Jpn., 128(12),1833-1837, 2008 |
|
Evaluation of Experience-oriented Hospital Practical Training by an Examination-Comparison of the Educational Effects on Clinical Knowledge and Problem-solving Abilities- |
| K. Suemaru, K. Takeichi, T. Yamaguchi, Y. Kohei, C. Okamoto, S. Ikazaki, K. Ido, M. Tanaka, Y. Miyoshi, T. Moriguchi, Y. Ikegawa, and H. Araki |
| J. Pharm. Soc. Jpn., 128(12),1839-1844, 2008 |
|
Preparation and Prodrug Studies of Quercetin Pentabenzensulfonate |
| Y. Peng, Z. Deng, and C. Wang |
| J. Pharm. Soc. Jpn., 128(12),1845-1849, 2008 |
|
Change in Characteristics of Human Mesenchymal Stem Cells during the In Vitro Culture-c-myc Gene Expression and Chromosome Aberrations at the c-myc locus- |
| R. Sawada, A. Matsuoka, Y. Matsuda, and T. Tsuchiya |
| J. Pharm. Soc. Jpn., 128(12),1851-1856, 2008 |
|